CLINICAL_TRIALS trial_result · 2013-10-29

Clinical Trial Update: Phase 3 Study of MAP0004 in Adult Migraineurs [Phase 3]

Phase 3 study of MAP0004 in adults with migraines has completed and results were posted in 2013. Sponsored by Allergan.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-10-29